Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

RGMA protein levels

TPM2 · rs2789750

Strength of the evidence

2 / 4

Its strongest genetic-study result is p = 10−39, with 2 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 47,745 European ancestry individuals.

The effect Each copy of the G allele shifted the measure 0.066 lower (95% confidence interval 0.055-0.077); p = 3 × 10−39.

How common The G allele had a frequency of about 32% in the people studied.

Where it sits Chromosome 9, band 9p13.3 — in an intron of TPM2.

What ClinVar records

Classification Benign; criteria provided, single submitter (1 of 4 stars, 1 submitter), last evaluated 2018-06-14. ClinVar record 670798 NM_003289.4(TPM2):c.773-235G>C

Change history MyGeneLog™ keeps a copy of every weekly release from 2026-10-19 and compares them. This position's classification has not changed since.

What this is ClinVar's aggregate record for this position (as of its 2026-11-16 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.

How common each version is

CG
Korean KRGDB
C 93.6% · G 6.4%
Korean Korea4K
C 93.6% · G 6.4%
Korean Korea1K
C 94.3% · G 5.7%
Japanese ToMMo
C 92.7% · G 7.3%
Vietnamese
C 90.6% · G 9.3%
World gnomAD
C 72.3% · G 27.7%
World 1000 Genomes
C 75.6% · G 24.4%
World TOPMed
C 72.6% · G 27.4%

By ancestry gnomAD

East Asian
C 91.1% · G 8.9%
European (non-Finnish)
C 66.3% · G 33.7%
African / African American
C 83.7% · G 16.3%
South Asian
C 62.9% · G 37.1%
Admixed American (Latino)
C 67.9% · G 32.1%
Middle Eastern
C 61.6% · G 38.4%
Finnish
C 69.7% · G 30.3%
Ashkenazi Jewish
C 67.7% · G 32.4%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

C/C No copy of the version the research linked to RGMA protein levels. This is the starting point the study compared everyone against.
C/G One copy of the version the research linked to RGMA protein levels. That is a smaller link than two copies.
G/G Two copies of the version the research linked to RGMA protein levels. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

RGMA protein levels (rs2789750). MyGeneLog™. https://www.mygenelog.com/variants/rs2789750

← See all variants